ARTICLE | Company News
Janus Biotherapeutics, Roche deal
October 19, 2015 7:00 AM UTC
Janus and Roche partnered exclusively to develop JB6121 to treat autoimmune disease. Janus will receive an upfront payment and R&D funding. Roche will have the option to acquire Janus following achie...